annual D&A:
$2.56M+$499.00K(+24.21%)Summary
- As of today (September 10, 2025), XENE annual depreciation & amortization is $2.56 million, with the most recent change of +$499.00 thousand (+24.21%) on December 31, 2024.
- During the last 3 years, XENE annual D&A has risen by +$1.65 million (+182.56%).
- XENE annual D&A is now at all-time high.
Performance
XENE Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$655.60K-$3400.00(-0.52%)Summary
- As of today (September 10, 2025), XENE quarterly depreciation & amortization is $655.60 thousand, with the most recent change of -$3400.00 (-0.52%) on June 1, 2025.
- Over the past year, XENE quarterly D&A has increased by +$23.30 thousand (+3.68%).
- XENE quarterly D&A is now -62.36% below its all-time high of $1.74 million, reached on September 30, 2023.
Performance
XENE quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.57M+$23.30K(+0.91%)Summary
- As of today (September 10, 2025), XENE TTM depreciation & amortization is $2.57 million, with the most recent change of +$23.30 thousand (+0.91%) on June 1, 2025.
- Over the past year, XENE TTM D&A has dropped by -$1.19 million (-31.70%).
- XENE TTM D&A is now -31.70% below its all-time high of $3.77 million, reached on June 30, 2024.
Performance
XENE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
XENE Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.2% | +3.7% | -31.7% |
| 3 y3 years | +182.6% | +76.2% | +111.7% |
| 5 y5 years | +496.7% | +302.2% | +395.1% |
XENE Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +182.6% | -62.4% | +92.0% | -31.7% | +111.7% |
| 5 y | 5-year | at high | +496.7% | -62.4% | +302.2% | -31.7% | +395.1% |
| alltime | all time | at high | +496.7% | -62.4% | +729.9% | -31.7% | +1370.5% |
XENE Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $655.60K(-0.5%) | $2.57M(+0.9%) |
| Mar 2025 | - | $659.00K(+12.0%) | $2.55M(+2.9%) |
| Dec 2024 | $2.56M(+24.2%) | $588.40K(-12.2%) | $2.48M(-8.1%) |
| Sep 2024 | - | $670.40K(+6.0%) | $2.70M(-28.4%) |
| Jun 2024 | - | $632.30K(+7.9%) | $3.77M(+0.7%) |
| Mar 2024 | - | $586.00K(-27.4%) | $3.74M(+6.6%) |
| Dec 2023 | $2.06M(+46.7%) | $807.60K(-53.6%) | $3.51M(+10.7%) |
| Sep 2023 | - | $1.74M(+187.7%) | $3.17M(+79.2%) |
| Jun 2023 | - | $605.40K(+71.0%) | $1.77M(+15.2%) |
| Mar 2023 | - | $354.00K(-24.3%) | $1.54M(-1.4%) |
| Dec 2022 | $1.41M(+55.1%) | $467.90K(+37.1%) | $1.56M(+14.7%) |
| Sep 2022 | - | $341.40K(-8.2%) | $1.36M(+11.7%) |
| Jun 2022 | - | $372.00K(-1.1%) | $1.22M(+12.4%) |
| Mar 2022 | - | $376.00K(+40.4%) | $1.08M(+20.0%) |
| Dec 2021 | $906.00K(+40.7%) | $267.90K(+34.3%) | $901.00K(+6.3%) |
| Sep 2021 | - | $199.50K(-16.0%) | $848.00K(+2.2%) |
| Jun 2021 | - | $237.60K(+21.2%) | $829.40K(+9.9%) |
| Mar 2021 | - | $196.00K(-8.8%) | $754.80K(+13.9%) |
| Dec 2020 | $644.00K(+50.1%) | $214.90K(+18.8%) | $662.80K(+11.6%) |
| Sep 2020 | - | $180.90K(+11.0%) | $594.00K(+14.3%) |
| Jun 2020 | - | $163.00K(+56.7%) | $519.80K(+13.9%) |
| Mar 2020 | - | $104.00K(-28.8%) | $456.20K(+5.8%) |
| Dec 2019 | $429.00K | $146.10K(+36.9%) | $431.20K(+2.2%) |
| Sep 2019 | - | $106.70K(+7.3%) | $422.10K(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $99.40K(+25.8%) | $454.60K(-9.8%) |
| Mar 2019 | - | $79.00K(-42.3%) | $504.20K(-12.3%) |
| Dec 2018 | $586.00K(-9.7%) | $137.00K(-1.6%) | $575.20K(-0.2%) |
| Sep 2018 | - | $139.20K(-6.6%) | $576.40K(-8.6%) |
| Jun 2018 | - | $149.00K(-0.7%) | $630.30K(-2.7%) |
| Mar 2018 | - | $150.00K(+8.5%) | $647.70K(-2.3%) |
| Dec 2017 | $649.00K(-24.9%) | $138.20K(-28.4%) | $662.70K(-1.4%) |
| Sep 2017 | - | $193.10K(+16.0%) | $672.40K(+4.9%) |
| Jun 2017 | - | $166.40K(+0.8%) | $641.10K(-13.5%) |
| Mar 2017 | - | $165.00K(+11.6%) | $740.90K(-13.6%) |
| Dec 2016 | $864.00K(-16.8%) | $147.90K(-8.6%) | $857.90K(-12.9%) |
| Sep 2016 | - | $161.80K(-39.2%) | $984.50K(-6.1%) |
| Jun 2016 | - | $266.20K(-5.6%) | $1.05M(-2.0%) |
| Mar 2016 | - | $282.00K(+2.7%) | $1.07M(+7.5%) |
| Dec 2015 | $1.04M(+40.7%) | $274.50K(+21.6%) | $994.60K(+10.1%) |
| Sep 2015 | - | $225.80K(-21.4%) | $903.50K(+4.8%) |
| Jun 2015 | - | $287.30K(+38.8%) | $862.00K(+15.0%) |
| Mar 2015 | - | $207.00K(+12.9%) | $749.70K(+4.5%) |
| Dec 2014 | $738.00K(+4.7%) | $183.40K(-0.5%) | $717.70K(+34.3%) |
| Sep 2014 | - | $184.30K(+5.3%) | $534.30K(+52.7%) |
| Jun 2014 | - | $175.00K(0.0%) | $350.00K(+100.0%) |
| Mar 2014 | - | $175.00K | $175.00K |
| Dec 2013 | $705.00K(-10.3%) | - | - |
| Dec 2012 | $786.00K(-30.6%) | - | - |
| Dec 2011 | $1.13M | - | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual D&A year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly D&A year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM D&A year-on-year change?
What is Xenon Pharmaceuticals Inc. annual depreciation & amortization?
The current annual D&A of XENE is $2.56M
What is the all time high annual D&A for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual depreciation & amortization is $2.56M
What is Xenon Pharmaceuticals Inc. annual D&A year-on-year change?
Over the past year, XENE annual depreciation & amortization has changed by +$499.00K (+24.21%)
What is Xenon Pharmaceuticals Inc. quarterly depreciation & amortization?
The current quarterly D&A of XENE is $655.60K
What is the all time high quarterly D&A for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly depreciation & amortization is $1.74M
What is Xenon Pharmaceuticals Inc. quarterly D&A year-on-year change?
Over the past year, XENE quarterly depreciation & amortization has changed by +$23.30K (+3.68%)
What is Xenon Pharmaceuticals Inc. TTM depreciation & amortization?
The current TTM D&A of XENE is $2.57M
What is the all time high TTM D&A for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM depreciation & amortization is $3.77M
What is Xenon Pharmaceuticals Inc. TTM D&A year-on-year change?
Over the past year, XENE TTM depreciation & amortization has changed by -$1.19M (-31.70%)